China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Clinical Study of a Thiotepa-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131714
Registration Time: 2026/09/06
Type: Interventional study
Primary Sponsor: Tianjin First Central Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341753
Published by HT Digital Content Services with permission from Health Daily Digest....